Ascom's latest offering, Ascom Myco, a smartphone with unique features designed to render nurses' work easier, catches the interest of Belgian hospitals and healthcare institutions. Philippe Bosmans, Sales Manager, Ascom Belgium and Tom Decoo, Senior Account Manager Healthcare, Nextel, a Belgium-based telecoms integrator, explain the benefits of the Ascom Myco and the added value it brings to the hospitals. 
Aridhia's data science platform AnalytiXagility has been chosen to underpin a €6 million oral healthcare innovation project funded by the EU’s Horizon 2020 programme and the funding win demonstrates huge confidence in Aridhia's data analytics capability. 
Cancer treatment is complex. The widely varying progressions of this disease require comprehensive diagnostics, an early check of treatment, and the exchange of information with colleagues. The new version of the diagnostics software syngo.via supports the treating physician in making decisions regarding treatment in oncology through a comprehensive portfolio of applications across imaging systems, treatments, and disciplines. 
Royal Philips (NYSE: PHG, AEX: PHIA) and Westchester Medical Center Health Network (WMCHealth) today announced a multi-year, USD 500 million partnership to transform and improve healthcare for millions of patients across New York's Hudson Valley. The partnership is based on an enterprise managed services model through which Philips will provide WMCHealth with a comprehensive range of clinical and business consulting services, 
Renowned health informatics leader Michael Thick has this week been appointed as chief medical officer (CMO) and chief clinical information officer (CCIO) of electronic patient record software pioneer IMS MAXIMS. 
Agfa HealthCare has signed a new three-year agreement with The Mid Yorkshire Hospitals NHS Trust for its picture archiving and communication system (PACS) extended with a high availability, vendor-neutral Enterprise Imaging platform. The contract was signed at the end of 2014, and implementation began in May 2015. 
Dell has announced its extended partnership with Translational Genomics Research Institute (TGen) to help clinical researchers and doctors globally expand the reach and impact of the world's first Food and Drug Administration (FDA)-approved personalized medicine trial for pediatric cancer.